RBMS3 and malignant colon neoplasm: In order to elucidate the molecular mechanism underlying RBMS3's inhibitory effects on colon cancer progression, we performed RNA‐seq analyses on cells overexpressing RBMS3, cells with RBMS3 knocked down, and a control group.